Prosecution Insights
Last updated: October 04, 2026
Application No. 18/794,724

Multiple Suture Placement System

Final Rejection §102
Filed
Aug 05, 2024
Priority
May 11, 2020 — provisional 63/022,632 +1 more
Examiner
KNAUSS, CHRISTIAN D
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Cypris Medical Inc.
OA Round
2 (Final)
71%
Grant Probability
Favorable
3-4
OA Rounds
1y 1m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 71% — above average
71%
Career Allowance Rate
304 granted / 427 resolved
+1.2% vs TC avg
Strong +33% interview lift
Without
With
+33.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
29 currently pending
Career history
463
Total Applications
across all art units

Statute-Specific Performance

§101
1.1%
-38.9% vs TC avg
§103
49.1%
+9.1% vs TC avg
§102
19.3%
-20.7% vs TC avg
§112
26.4%
-13.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 427 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment Claims 36 and 38-40 are pending in the application. Claims 1-35, 37, and 41-107 have been canceled. Claims 36 and 38 have been amended. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 36 and 38-40 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Gambale et al. (US 2003/0208209 A1) (“Gambale”). Regarding claim 36, Gambale discloses (Figures 11A-11D, 19-21, 24-27) an apparatus, comprising: a suturing probe (500) having a first and a second suturing probe recessed external surface said first suturing probe recessed external surface (depicted in Figure 27) delimiting a first open area (see Figure 11A annotated below) and said second suturing probe recessed external surface (mirrored on the opposite side of the probe, paragraph 0137) delimiting a second open area; said first and second recessed external surfaces oppositely facing (paragraphs 0136-0137); a first and a second thread capture chamber (520), said first thread capture chamber opening into said first open area and said second thread capture chamber opening into said second open area (paragraph 0137); a first and second substrate capture chamber (504), said first substrate capture chamber having a respective first chamber port (see Figure 11A annotated below) open to said first open area, said second substrate capture chamber having a respective second chamber port open to said second open area, wherein said first chamber port defines a transition edge (see Figure 11A annotated below) circumscribing said first substrate capture chamber and delimiting an entry into said first substrate capture chamber at an exit of said first open area, said first chamber port encompassing an open space having a reduced volume (the open space is shown between the annotated open area in Figure 11A below and the annotated substrate capture chamber in Figure 11A below) compared to an open space encompassed by said entry (diagonally hashed section in Figure 11A below) into said first open area (see Figure 11A annotated below); a pair of thread carrier passages (516, 518) opening into each of said first and second open recessed areas of said suturing probe first and second recessed external surfaces (Figures 24 and 27); and a pair of thread carriers (506) correspondingly slidably engaged in said pair of thread carrier passages, each of said pair of thread carriers correspondingly extendable from said pair of thread carrier passages within said first and second open areas defined by said first and second external recessed surfaces and outside of said substrate capture chambers into a corresponding one of said pair of thread capture chambers (Figure 24; paragraphs 0136-0137). PNG media_image1.png 412 482 media_image1.png Greyscale Regarding claim 38, Gambale discloses a vacuum source fluidically coupled to said substrate capture chambers, said vacuum source operable to generate a reduction in chamber pressure in said substrate capture chambers sufficient to capture a first substrate and a second substrate at each of said first and second chamber ports (paragraphs 0012, 0103, 0112, 0135). Regarding claim 39, Gambale discloses that upon capture of said first and second substrates at each of said first and second chamber ports, a first of said pair of thread carriers can pass through a portion of said first substrate disposed in said first open area delimited by said first external recessed surface and a second of said pair of thread carriers can pass through a portion of said second substrate disposed in said second open area delimited by said second external recessed surface (paragraph 0137). Regarding claim 40, Gambale discloses a first and second thread (326) correspondingly carried by said first and second thread carriers, each of said first and second threads correspondingly captured by said pair of thread capture chambers (paragraphs 0131, 0137). Response to Arguments Applicant’s arguments with respect to claims 36 and 38-40 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. A new interpretation of the Gambale reference has been presented in view of the change in claim scope. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to CHRISTIAN D KNAUSS whose telephone number is (571)272-8641. The examiner can normally be reached M-F 12:30-8:30. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Darwin Erezo can be reached at 571-272-4695. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /C.D.K/Examiner, Art Unit 3771 /DIANE D YABUT/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Aug 05, 2024
Application Filed
Jan 08, 2026
Non-Final Rejection mailed — §102
Jun 26, 2026
Response Filed
Sep 08, 2026
Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12714600
NEW AND IMPROVED VITRECTOR AND METHOD FOR PERFORMING A ONE-STEP POSTERIOR VITRECTOMY USING THE SAME
4y 9m to grant Granted Aug 25, 2026
Patent 12714457
ATHERECTOMY CATHETERS HAVING MOVABLE BEADS
1y 10m to grant Granted Aug 25, 2026
Patent 12702401
Surgical Constructs for Tissue Fixation and Methods of Tissue Repairs
5y 10m to grant Granted Aug 11, 2026
Patent 12702396
ARTICULATING SUTURING DEVICE
3y 3m to grant Granted Aug 11, 2026
Patent 12702427
HEMOSTATIC DEVICE AND HEMOSTATIC METHOD
3y 3m to grant Granted Aug 11, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
71%
Grant Probability
99%
With Interview (+33.4%)
3y 3m (~1y 1m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 427 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month